You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
艾力斯(688578.SH):銷售策略的差異化主要源於產品的差異化
格隆匯 08-02 15:35

格隆匯8月2日丨艾力斯(688578.SH)近期在接待機構投資者調研時表示,我們銷售策略的差異化主要源於我們產品的差異化。與其他產品相比,伏美替尼具有差異化優勢,是具有突破性的第三代EGFR-TKI。在分子結構方面,伏美替尼采用創新藥物設計,在分子設計、化學結構、代謝性質、藥理活性等方面均實現了技術突破,並最終體現在優異的臨牀療效和安全性上,伏美替尼具有“腦轉強效、療效優異、安全性佳、治療窗寬”等產品特點,並且對肺癌患者常見的腦部轉移病灶具有良好療效,實現了產品差異化的鮮明特色和競爭優勢。

基於伏美替尼的產品優勢,公司制定了差異化的銷售策略,通過專業化、差異化的學術推廣模式,向臨牀醫生傳遞伏美替尼的差異化優勢。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account